David Katzenstein

Division of Infectious Diseases and Geographic Medicine, Stanford Medical School

Research Area

Biography

David Katzenstein has not added Biography.
If you are David Katzenstein and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 37	2014

Other Publications

Article	Year
Association of high HIV-1 RNA levels and homozygosity at HLA class II DRB1 in adults coinfected with Mycobacterium tuberculosis in Harare, Zimbabwe. Human immunology\| PubMed ID: 12392855	2002
Regulatory concerns regarding AIDS vaccine development. AIDS & public policy journal\| PubMed ID: 11650100	1988
Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels. AIDS (London, England)\| PubMed ID: 11834952	2002
Clinical signs and symptoms in the assessment of immunodeficiency in men with subtype C HIV infection in Harare, Zimbabwe. HIV clinical trials\| PubMed ID: 11976993	2002
Maternal HIV-1 antibody and vertical transmission in subtype C virus infection. Journal of acquired immune deficiency syndromes (1999)\| PubMed ID: 11981358	2002
A Phase I, placebo-controlled trial of multi-dose recombinant human interleukin-12 in patients with HIV infection. AIDS (London, England)\| PubMed ID: 12004273	2002
Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. JAMA : the journal of the American Medical Association\| PubMed ID: 12095387	2002
Durability of response to treatment among antiretroviral-experienced subjects: 48-week results from AIDS Clinical Trials Group Protocol 359. The Journal of infectious diseases\| PubMed ID: 12195349	2002
Subtle decreases in stavudine phenotypic susceptibility predict poor virologic response to stavudine monotherapy in zidovudine-experienced patients. Journal of acquired immune deficiency syndromes (1999)\| PubMed ID: 12394789	2002
Antiretroviral treatment in resource-poor settings: clinical research priorities. Lancet\| PubMed ID: 12433534	2002
Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapy. The Journal of infectious diseases\| PubMed ID: 12508159	2003
HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy. AIDS research and human retroviruses\| PubMed ID: 12512512	2002
Editorial comment: resistance testing--an integral part of HIV management. The AIDS reader\| PubMed ID: 12569893	2003
Phenotypic susceptibility and virological outcome in nucleoside-experienced patients receiving three or four antiretroviral drugs. AIDS (London, England)\| PubMed ID: 12660529	2003
Editorial comment: interpretation of resistance tests remains complex. The AIDS reader\| PubMed ID: 12728869	2003
High frequency of syncytium-inducing and CXCR4-tropic viruses among human immunodeficiency virus type 1 subtype C-infected patients receiving antiretroviral treatment. Journal of virology\| PubMed ID: 12805470	2003
Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution. AIDS reviews\| PubMed ID: 12875105	2003
Clinical impact of the M184V mutation on switching to didanosine or maintaining lamivudine treatment in nucleoside reverse-transcriptase inhibitor-experienced patients. The Journal of infectious diseases\| PubMed ID: 12898440	2003
Assessing resistance costs of antiretroviral therapies via measures of future drug options. The Journal of infectious diseases\| PubMed ID: 14513420	2003
The evaluation of the HIV/AIDS drug access initiatives in Côte d'Ivoire, Senegal and Uganda: how access to antiretroviral treatment can become feasible in Africa. AIDS (London, England)\| PubMed ID: 14565603	2003
Evaluation of cutpoints for phenotypic hypersusceptibility to efavirenz. AIDS (London, England)\| PubMed ID: 14571193	2003
Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 months. Journal of acquired immune deficiency syndromes (1999)\| PubMed ID: 14657758	2003
Drug resistance in non-subtype B HIV-1. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology\| PubMed ID: 14962783	2004
Genotype, phenotype, and virtual phenotype: who needs what and why? Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)\| PubMed ID: 14986515	2003
Mycobacterium tuberculosis/HIV-1 coinfection and disease: role of human leukocyte antigen variation. The Journal of infectious diseases\| PubMed ID: 14999612	2004
Infant feeding practices of HIV-infected and uninfected women in Zimbabwe. AIDS patient care and STDs\| PubMed ID: 15006194	2004
HIV/AIDS care and treatment in sub-Saharan Africa. AIDS reviews\| PubMed ID: 15011998	2003
Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load. Journal of virology\| PubMed ID: 15016844	2004
Sex-based differences in saquinavir pharmacology and virologic response in AIDS Clinical Trials Group Study 359. The Journal of infectious diseases\| PubMed ID: 15031785	2004
The longer the better? Four years of durable, initially boosted protease treatment. AIDS (London, England)\| PubMed ID: 15075518	2004
Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy. AIDS (London, England)\| PubMed ID: 15238768	2004
Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. JAMA : the journal of the American Medical Association\| PubMed ID: 15249575	2004
Weighted phenotypic susceptibility scores are predictive of the HIV-1 RNA response in protease inhibitor-experienced HIV-1-infected subjects. The Journal of infectious diseases\| PubMed ID: 15295692	2004
Genetic correlates of efavirenz hypersusceptibility. AIDS (London, England)\| PubMed ID: 15316338	2004
Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 15383595	2004
T lymphocytes among HIV-infected and -uninfected infants: CD4/CD8 ratio as a potential tool in diagnosis of infection in infants under the age of 2 years. Journal of translational medicine\| PubMed ID: 15683549	2005
Antiretroviral rounds. Resistance: how do you know if you don't know? AIDS clinical care\| PubMed ID: 15828117	2005
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration. PLoS medicine\| PubMed ID: 15839752	2005
Nonnucleoside reverse transcriptase inhibitor phenotypic hypersusceptibility can be demonstrated in different assays. Journal of acquired immune deficiency syndromes (1999)\| PubMed ID: 15851917	2005
Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern Africa. AIDS research and human retroviruses\| PubMed ID: 15943570	2005
HIV type 1 genotypic variation in an antiretroviral treatment-naive population in southern India. AIDS research and human retroviruses\| PubMed ID: 15943572	2005
Among the devils in the details are protease sequence, susceptibility, and structure in CRF02_AG viruses. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America\| PubMed ID: 15983924	2005
Signal-boosted qualitative ultrasensitive p24 antigen assay for diagnosis of subtype C HIV-1 infection in infants under the age of 2 years. Journal of acquired immune deficiency syndromes (1999)\| PubMed ID: 16010158	2005
Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine. The Journal of infectious diseases\| PubMed ID: 16136470	2005
The feasibility of voluntary counselling and HIV testing for pregnant women using community volunteers in Zimbabwe. International journal of STD & AIDS\| PubMed ID: 16303072	2005
The HIV-1 Non-subtype B Workgroup: an international collaboration for the collection and analysis of HIV-1 non-subtype B data. MedGenMed : Medscape general medicine\| PubMed ID: 16369376	2005
Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent. Antimicrobial agents and chemotherapy\| PubMed ID: 16436728	2006
HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes. AIDS (London, England)\| PubMed ID: 16514293	2006
Of molecules, macaques and global AIDS. AIDS (London, England)\| PubMed ID: 16603861	2006
A pilot study evaluating time to CD4 T-cell count <350 cells/mm(3) after treatment interruption following antiretroviral therapy +/- interleukin 2: results of ACTG A5102. Journal of acquired immune deficiency syndromes (1999)\| PubMed ID: 16760795	2006
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA : the journal of the American Medical Association\| PubMed ID: 16905788	2006
Affordable flow cytometry for enumeration of absolute CD4+ T-lymphocytes to identify subtype C HIV-1 infected adults requiring antiretroviral therapy (ART) and monitoring response to ART in ... Journal of translational medicine\| PubMed ID: 16907973	2006
Diversity, drug resistance, and the epidemic of subtype C HIV-1 in Africa. The Journal of infectious diseases\| PubMed ID: 16921472	2006
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel. Topics in HIV medicine : a publication of the International AIDS Society, USA\| PubMed ID: 17016878	2006
Factors in the delayed HIV presentation of immigrants in Northern California: implications for voluntary counseling and testing programs. Journal of immigrant and minority health / Center for Minority Public Health\| PubMed ID: 17031578	2007
Perceived risks and benefits of HIV testing, and predictors of acceptance of HIV counselling and testing among pregnant women in Zimbabwe. International journal of STD & AIDS\| PubMed ID: 17212862	2006
Non-nucleoside phenotypic hypersusceptibility cut-point determination from ACTG 359. HIV clinical trials\| PubMed ID: 17507321	2007
More on the treatment-tropism relationship: the impact of prior antiretroviral treatment on HIV coreceptor tropism among subjects entering AIDS clinical trials group 175. The Journal of infectious diseases\| PubMed ID: 17570122	2007
Laboratory indicators of mastitis are not associated with elevated HIV-1 DNA loads or predictive of HIV-1 RNA loads in breast milk. The Journal of infectious diseases\| PubMed ID: 17624843	2007
Drug resistance in plasma and breast milk after single-dose nevirapine in subtype C HIV type 1: population and clonal sequence analysis. AIDS research and human retroviruses\| PubMed ID: 17725424	2007
Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk. PloS one\| PubMed ID: 18431498	2008
Genotypic susceptibility scores and HIV type 1 RNA responses in treatment-experienced subjects with HIV type 1 infection. AIDS research and human retroviruses\| PubMed ID: 18462083	2008
Cytomegalovirus and Epstein-Barr virus in breast milk are associated with HIV-1 shedding but not with mastitis. AIDS (London, England)\| PubMed ID: 18614868	2008
Cost-effectiveness of HIV monitoring strategies in resource-limited settings: a southern African analysis. Archives of internal medicine\| PubMed ID: 18809819	2008
Editorial comment: a plethora or options in multidrug-resistant HIV-1 infection. The AIDS reader\| PubMed ID: 18828232	2008
Bayesian network analyses of resistance pathways against efavirenz and nevirapine. AIDS (London, England)\| PubMed ID: 18832874	2008
Envelope coreceptor tropism, drug resistance, and viral evolution among subtype C HIV-1-infected individuals receiving nonsuppressive antiretroviral therapy. Journal of acquired immune deficiency syndromes (1999)\| PubMed ID: 19295330	2009
CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic. Journal of virology\| PubMed ID: 19297481	2009
Lack of evidence for frequent heterosexual transmission of human herpesvirus 8 in Zimbabwe. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America\| PubMed ID: 19400749	2009
Expanding antiretroviral options in resource-limited settings--a cost-effectiveness analysis. Journal of acquired immune deficiency syndromes (1999)\| PubMed ID: 19448557	2009
TREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratories. Journal of virological methods\| PubMed ID: 19490972	2009
Evaluation of two human immunodeficiency virus-1 genotyping systems: ViroSeq 2.0 and an in-house method. Journal of virological methods\| PubMed ID: 19490976	2009
Evolution and molecular epidemiology of subtype C HIV-1 in Zimbabwe. AIDS (London, England)\| PubMed ID: 19770693	2009
The HIV-1 Non-subtype B Workgroup: An International Collaboration for the Collection and Analysis of HIV-1 Non-subtype B Data. Journal of the International AIDS Society\| PubMed ID: 19825127	2005
Genotypic HIV type-1 drug resistance among patients with immunological failure to first-line antiretroviral therapy in south India. Antiviral therapy\| PubMed ID: 19918105	2009
Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy. The New England journal of medicine\| PubMed ID: 19952143	2009
Learning and doing: operational research and access to HIV treatment in Africa. AIDS (London, England)\| PubMed ID: 20023435	2010
Quality of life, psychosocial health, and antiretroviral therapy among HIV-positive women in Zimbabwe. AIDS care\| PubMed ID: 20024731	2009
Unusual five amino acid insert within subtype C HIV-1 envelope contributes to dual-tropism (X4R5). AIDS (London, England)\| PubMed ID: 20299967	2010
Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa. AIDS (London, England)\| PubMed ID: 20453629	2010
Nucleic acid template and the risk of a PCR-Induced HIV-1 drug resistance mutation. PloS one\| PubMed ID: 20539818	2010
Genetic analyses of HIV-1 env sequences demonstrate limited compartmentalization in breast milk and suggest viral replication within the breast that increases with mastitis. Journal of virology\| PubMed ID: 20660189	2010
Viral sequence analysis from HIV-infected mothers and infants: molecular evolution, diversity, and risk factors for mother-to-child transmission. Clinics in perinatology\| PubMed ID: 21078447	2010
Fertility desires and condom use among HIV-positive women at an antiretroviral roll-out program in Zimbabwe. African journal of reproductive health\| PubMed ID: 21243916	2010
Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study. BMC public health\| PubMed ID: 21303548	2011
Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1. Annals of internal medicine\| PubMed ID: 21320923	2011
Adherence to drug-refill is a useful early warning indicator of virologic and immunologic failure among HIV patients on first-line ART in South Africa. PloS one\| PubMed ID: 21408071	2011
Lower CD4 cell count and higher virus load, but not antiretroviral drug resistance, are associated with AIDS-defining events and mortality: an ACTG Longitudinal Linked Randomized Trials (ALL... HIV clinical trials\| PubMed ID: 21498151	2011
Detection of HIV-1 in Saliva: Implications for Case-Identification, Clinical Monitoring and Surveillance for Drug Resistance. The open virology journal\| PubMed ID: 21673840	2010
Surveillance of transmitted antiretroviral drug resistance among HIV-1 infected women attending antenatal clinics in Chitungwiza, Zimbabwe. PloS one\| PubMed ID: 21698125	2011
Placental malaria and mother-to-child transmission of human immunodeficiency virus-1 in rural Rwanda. The American journal of tropical medicine and hygiene\| PubMed ID: 21813835	2011
HIV disclosure patterns, predictors, and psychosocial correlates among HIV positive women in Zimbabwe. AIDS care\| PubMed ID: 21902570	2012
Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results. The Journal of infectious diseases\| PubMed ID: 21917892	2011
Drug resistance patterns and virus re-suppression among HIV-1 subtype C infected patients receiving non-nucleoside reverse transcriptase inhibitors in South Africa. Journal of AIDS & clinical research\| PubMed ID: 21927716	2011
The point of point-of-care testing. Lancet\| PubMed ID: 22035547	2011
Reverse transcriptase substitution at codons 208 and 228 among treatment-experienced HIV-1 subtype-C-infected Indian patients is strongly associated with thymidine analogue mutations. Journal of acquired immune deficiency syndromes (1999)\| PubMed ID: 22245718	2012
Primary drug resistance in South Africa: data from 10 years of surveys. AIDS research and human retroviruses\| PubMed ID: 22251009	2012
The incidence and correlates of symptomatic and asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae infections in selected populations in five countries. Sexually transmitted diseases\| PubMed ID: 22256336	2011
Viremia and HIV-1 drug resistance mutations among patients receiving second-line highly active antiretroviral therapy in Chennai, Southern India. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America\| PubMed ID: 22323567	2012
Zidovudine (AZT) monotherapy selects for the A360V mutation in the connection domain of HIV-1 reverse transcriptase. PloS one\| PubMed ID: 22363673	2012
Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings. AIDS (London, England)\| PubMed ID: 22441252	2012
Panel of prototypical recombinant infectious molecular clones resistant to nevirapine, efavirenz, etravirine, and rilpivirine. Antimicrobial agents and chemotherapy\| PubMed ID: 22664973	2012
Global analysis of sequence diversity within HIV-1 subtypes across geographic regions. Future virology\| PubMed ID: 22822410	2012
Comparing Peripheral Blood Mononuclear Cell DNA and Circulating Plasma viral RNA pol Genotypes of Subtype C HIV-1. Journal of AIDS & clinical research\| PubMed ID: 23019537	2012
HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease status. The Journal of infectious diseases\| PubMed ID: 23148287	2012
Antiviral resistance and correlates of virologic failure in the first cohort of HIV-infected children gaining access to structured antiretroviral therapy in Lima, Peru: a cross-sectional ana... BMC infectious diseases\| PubMed ID: 23280237	2013
In vitro HIV-1 evolution in response to triple reverse transcriptase inhibitors & in silico phenotypic analysis. PloS one\| PubMed ID: 23613794	2013
Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out st... The Journal of infectious diseases\| PubMed ID: 23687292	2013
Prototypical Recombinant Multi-Protease Inhibitor Resistant Infectious Molecular Clones of Human Immunodeficiency Virus Type-1. Antimicrobial agents and chemotherapy\| PubMed ID: 23796938	2013
Capacity building and predictors of success for HIV-1 drug resistance testing in the Asia-Pacific region and Africa. Journal of the International AIDS Society\| PubMed ID: 23845227	2013
HIV RNA and genotype in resource-limited settings: can we do better? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America\| PubMed ID: 24076967	2014
Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabine. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America\| PubMed ID: 24253247	2014
Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202. HIV clinical trials\| PubMed ID: 24334181	2013